Banco Bilbao Vizcaya Argentaria S.A. Boosts Holdings in Johnson & Johnson $JNJ

Banco Bilbao Vizcaya Argentaria S.A. increased its position in shares of Johnson & Johnson (NYSE:JNJ) by 0.8% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 201,848 shares of the company’s stock after buying an additional 1,600 shares during the quarter. Banco Bilbao Vizcaya Argentaria S.A.’s holdings in Johnson & Johnson were worth $30,822,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in JNJ. GFG Capital LLC purchased a new position in shares of Johnson & Johnson during the 2nd quarter worth $35,000. Stone House Investment Management LLC acquired a new position in Johnson & Johnson in the first quarter valued at about $47,000. 1248 Management LLC acquired a new position in Johnson & Johnson in the first quarter valued at about $48,000. Harvest Fund Management Co. Ltd purchased a new position in Johnson & Johnson during the first quarter worth about $52,000. Finally, Pandora Wealth Inc. acquired a new stake in shares of Johnson & Johnson during the first quarter valued at about $65,000. 69.55% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the stock. Royal Bank Of Canada restated an “outperform” rating and issued a $209.00 price objective on shares of Johnson & Johnson in a report on Friday, October 10th. Raymond James Financial boosted their target price on Johnson & Johnson from $174.00 to $209.00 and gave the company an “outperform” rating in a research report on Wednesday, October 15th. Johnson Rice set a $190.00 price target on Johnson & Johnson and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. Loop Capital set a $190.00 price objective on Johnson & Johnson in a research note on Wednesday, October 22nd. Finally, Wall Street Zen raised Johnson & Johnson from a “hold” rating to a “buy” rating in a research note on Saturday, September 13th. Three investment analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and nine have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $200.52.

Insider Transactions at Johnson & Johnson

In other Johnson & Johnson news, EVP Jennifer L. Taubert sold 56,471 shares of the business’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $177.81, for a total transaction of $10,041,108.51. Following the completion of the transaction, the executive vice president owned 178,013 shares in the company, valued at $31,652,491.53. The trade was a 24.08% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.16% of the stock is owned by corporate insiders.

Johnson & Johnson Stock Up 0.4%

Johnson & Johnson stock opened at $195.19 on Friday. The firm has a market capitalization of $470.27 billion, a P/E ratio of 18.84, a P/E/G ratio of 2.19 and a beta of 0.38. The stock’s fifty day simple moving average is $185.46 and its 200-day simple moving average is $169.66. Johnson & Johnson has a twelve month low of $140.68 and a twelve month high of $196.00. The company has a current ratio of 1.07, a quick ratio of 0.80 and a debt-to-equity ratio of 0.50.

Johnson & Johnson (NYSE:JNJ) last released its earnings results on Wednesday, August 30th. The company reported $2.26 EPS for the quarter. The firm had revenue of $24.02 billion during the quarter. Johnson & Johnson had a return on equity of 32.73% and a net margin of 27.26%. As a group, equities analysts expect that Johnson & Johnson will post 10.58 earnings per share for the current fiscal year.

Johnson & Johnson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 9th. Investors of record on Tuesday, November 25th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Tuesday, November 25th. This represents a $5.20 annualized dividend and a yield of 2.7%. Johnson & Johnson’s dividend payout ratio (DPR) is 50.19%.

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.